Quick Answer
Arcadia Biosciences, Inc. reported Earnings Per Share Diluted of $1.71 (loss) per share for the year ending 2025.
- Arcadia Biosciences, Inc. showed an increase of +66.9% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Arcadia Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: $0.29 per share | Q1 2021: $0.11 per share | Q2 2021: $0.24 (loss) per share | Q3 2021: $0.10 (loss) per share | Q1 2022: $8.09 (loss) per share | Q2 2022: $6.81 (loss) per share | Q3 2022: $4.67 (loss) per share | Q1 2023: $10.86 (loss) per share | Q2 2023: $0.61 per share | Q3 2023: $1.89 (loss) per share | Q1 2024: $1.78 (loss) per share | Q2 2024: $0.78 per share | Q3 2024: $1.18 (loss) per share | Q1 2025: $1.90 per share | Q2 2025: $3.26 (loss) per share | Q3 2025: $0.62 per share.
- Over the full 5 years of available data (2021 to 2025), Arcadia Biosciences, Inc.'s Earnings Per Share Diluted has grown by 93.8%.
- Historical annual values: Fiscal year 2025: $1.71 (loss) per share | Fiscal year 2024: $5.17 (loss) per share | Fiscal year 2023: $11.29 (loss) per share | Fiscal year 2022: $25.65 (loss) per share | Fiscal year 2021: $27.56 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: